ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,924Medicare Part D Prescriptions Filled, Including Refills

Rank: 256 out of 1185

$592K Total Retail Price of All Prescriptions

Rank: 197 out of 1185

561 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,555 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 402 387 1 1
SIMVASTATIN 328 292 2 5
ZOLPIDEM TARTRATE 287 263 3 15
ATORVASTATIN CALCIUM 264 256 4 11
OMEPRAZOLE 258 205 5 6
LISINOPRIL 233 198 6 4
LOSARTAN-HYDROCHLOROTHIAZIDE 191 190 7 36
HYDROCODONE-ACETAMINOPHEN 175 128 S3 8 2
LEVOTHYROXINE SODIUM 166 146 9 3
PRAVASTATIN SODIUM 148 140 10 7
TAMSULOSIN HCL 148 127 10 34
METOPROLOL TARTRATE 146 116 12 10
METOPROLOL SUCCINATE 145 118 13 20
TRAMADOL HCL 144 126 14 16
METFORMIN HCL ER 117 102 15 35
WARFARIN SODIUM 115 101 16 21
CITALOPRAM HBR 109 93 17 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 104 18 14
CRESTOR 100 83 19 23
AZITHROMYCIN 98 80 20 39
DIOVAN 97 85 21 37
FLUTICASONE PROPIONATE 95 93 22 29
NEXIUM 94 68 23 19
GABAPENTIN 90 70 24 13
METFORMIN HCL 86 75 25 9
LOSARTAN POTASSIUM 79 73 26 26
ADVAIR DISKUS 78 43 27 54
HYDROCHLOROTHIAZIDE 75 71 28 12
FUROSEMIDE 73 63 29 8
CIPROFLOXACIN HCL 71 64 30 62
MELOXICAM 67 56 31 27
DONEPEZIL HCL 67 67 31 32
ALENDRONATE SODIUM 67 67 31 40
FINASTERIDE 65 65 34 132
ZETIA 65 41 34 78
RAMIPRIL 63 63 36 135
SYNTHROID 57 53 37 61
TRAZODONE HCL 55 46 38 38
SERTRALINE HCL 53 33 39 25
GLIMEPIRIDE 50 41 40 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.